Rocket One (RKTO) Retained Earnings (2017 - 2026)
Rocket One's (RKTO) quarterly Retained Earnings came in at $87.6 million in Q2 2026, up 15.54% year-over-year from $75.8 million in Q2 2025, and up 9.88% quarter-over-quarter from $79.7 million in Q1 2026.
Analysis
Rocket One (RKTO) Retained Earnings (2017 - 2026) Analysis & Trends
Rocket One has disclosed Retained Earnings across 10 years of filings, most recently posting $87.6 million for Q2 2026.
- In Q2 2026, Retained Earnings rose 15.54% year-over-year to $87.6 million; the TTM figure through Jun 2026 stood at $87.6 million (up 15.54% YoY), while the FY2025 annual figure was $79.0 million, up 17.45% from the prior year.
- Retained Earnings came in at $87.6 million for Q2 2026 at Rocket One, up from $79.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $87.6 million in Q2 2026 to a low of -$58.3 million in Q3 2024.
- Average Retained Earnings over 5 years is $21.8 million, with a median of $50.2 million recorded in 2022.
- Year-over-year, Retained Earnings slumped 4585.59% in 2022 and soared 239.93% in 2023.
- Over 5 years, Retained Earnings stood at -$44.1 million in 2022, then soared by 239.93% to $61.7 million in 2023, then climbed by 8.99% to $67.3 million in 2024, then grew by 17.45% to $79.0 million in 2025, then rose by 10.85% to $87.6 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $87.6 million in Q2 2026, $79.7 million in Q1 2026, and $79.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 5.13 Bn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 87.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.59 Mn |
| Mar 31, 2026 | 79.72 Mn |
| Dec 31, 2025 | 79.02 Mn |
| Sep 30, 2025 | 78.41 Mn |
| Jun 30, 2025 | 75.82 Mn |
| Mar 31, 2025 | 75.42 Mn |
| Dec 31, 2024 | 67.28 Mn |
| Sep 30, 2024 | -58.31 Mn |
| Jun 30, 2024 | -56.08 Mn |
| Mar 31, 2024 | -54.37 Mn |
| Dec 31, 2023 | 61.73 Mn |
| Sep 30, 2023 | -50.42 Mn |
| Jun 30, 2023 | -48.25 Mn |
| Mar 31, 2023 | -46.35 Mn |
| Dec 31, 2022 | -44.12 Mn |
| Sep 30, 2022 | 50.18 Mn |
| Jun 30, 2022 | 50.17 Mn |
| Mar 31, 2022 | 44.17 Mn |
| Dec 31, 2021 | 983,497.00 |
| Sep 30, 2021 | 43.57 Mn |